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THE rate of growth of human tumours is in clinical practice generally deter-
mined by a visual comparison of tumour sizes as displayed by a series of radio-
graphs. Collins, Loeffler and Tivey (1956) found, at the time of their study of
human tumours, that there were no quantitative terms for tumour-growth rate
in clinical use. Their work was mainly concerned with the justification of using
the concept of doubling time as a consequence of exponential growth, suggested
by them as a hypothesis. They also considered the use of this concept in predict-
ing the course of a disease. Since then there have been a number of growth-rate
studies on human tumours and metastases (Schwartz, 1961 ; Garland, Coulson
and Wl'ollin, 1963; Spratt, Spjut and Roper, 1963; Breur, 1965). So far, how-
ever, very little can be said regarding the laws of tumour growth.
In this paper we present some data on growth rates measured from radiographs
obtained in ordinary clinical diagnostics.
METHODS
As a measure of the volume of a metastasis or a tumour we have used a " rela-
tive volume" defined as the volume of an ellipsoid with the semiaxes equal to
three dimensions of the shadows measured from the radiographs. These dimen-
sions were in most cases taken as the breadth 2a and 2b and the height 2c of the
shadows obtained from the antero-posterior and the lateral pictures. In the
case of definitely oblate or prolate shadows, the semiaxes of the shadows were
applied. Th-e volume of the ellipsoid is 47r abc/3. This relative volume and
the real volume of the measured body are equal in the special case when the body
is oriented in the three directions corresponding to the three dimensions a, b and c.
If only one radiograph could be used, two dimensions were obtained by taking
as the third dimension the mean of the measured semiaxes. It is obvious that
the determination of the volume of very eccentric ellipsoids will be erroneous.
The method used here is, however, justified by the fact that it gives a correct size
if the body is spherical, and gives a fairly good approximation for slightly ellipsoid
shapes. If the shape remains unchanged during growth the calculated volume
will be proportional to the real volume, i.e. the ratio between the calculated and
the real volume would be constant during growth.
* Present address: Department of Physics, Abo Akademi, Abo, Finland.
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Breur (1965, p. 41) has pointed out that pulmonary metastases are rarely
solitary, being rather compounded of a number of small tightly-packed spherical
nodules. By measuring these parts individually he has obviously reduced an
error introduced by calculating tumour size from non-circular shadows corres-
ponding to non-spherical bodies. We have observed the structure mentioned by
Breur in some of the sharply-bounded shadows of our material, and we applied
it to so some of the metastases. No considerable change in the results was seen,
however, as shown typically in Fig. lb, although Breur's technique may be superior
to ours in the case of sharp shadows.
time one month per scale div.
FIG. 1. (a) The disappearance of pulmonary metastases as a result of the extirpation of the
primary tumour at A. (b) Growth of a metastasis in another case with retardation of
growth due to treatment. Solid curve obtained by measuring three dimensions. Broken
curve shows the growth of one spherical nodule of the metastasis.
The number of cells in a tumour or a metastasis is the most fundamental
measure of the tumour size. The volume is proportional to this number only if
the mean effective volume per cell rcmains constant during the growth. The
density of the neoplasm, however, may change owing to infections, change in
stroma, change in vascularity, etc. During a long-term study such incidental
changes may be seen as irregularities on the growth curve.
MATERIAL
We have studied 34 series of radiographs of the chest presenting primary
tumours of the lung and pulmonary metastases of different origin. The number
of pictures in the series varied between 2 and 14, and the time elapsed between
the first and the last radiograph was 4 to 40 months.
The size of pulmonary tumours and metastases was measured from as many
chest radiographs and fluoro-photographs as was practicable. An attempt was
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made to obtain a record of the growth over as long a period of time as possible.
A long record enables one to see the gross features of the growth and to avoid
mistaking incidental changes and errors for real effects. This is important with
a material that is collected from standard radiographs taken in clinical routine,
because the irregular quality of the pictures may give more scattering of the
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time two months per scale div.
FIG. 2.-Exponential growth of a metastasis.
measured data. Such a long-term curve is presented in Fig. 2
beautiful linear behaviour in the logarithmic plot.
and it shows a
CHANGE OF GROWTH RATE
We may use as a measure of growth rate the relative change in size per unit
time. Using the notation of the calculus we could accordingly write
I dV I dN
growth rate = or dt
in the case of a growth rate ofthe volume V or the number of cells N respectively.
At a certain instant of time it can be expressed in percentage of the tumour
volume per time unit.
The growth rate can be read from the growth curves as shown in Fig. 3. At
the beginning of the period studied the volume increases by 70% in one month.
Eight months later the rate is smaller, or 18%, as a result of treatment of the
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FIG. 3. The effect of treatment on the growth of metastases: I Sendoxan, II Diadreson,
III Thiotepa plus Sendoxan, IV SPJ.
patient with chemotherapeutic agents. It is obvious that a change in growth
rate on a curve is ofclinical interest, e.g. as an indication ofthe effect oftreatment.
In a subjective visual study of radiographs considerable changes in growth rate
may pass unobserved.
If the growth rate as defined above is constant, the growth is exponential,
as is shown by elementary calculus. The size can then be expressed.
V = VO e1n2 (1)
V0 is the volume at the start of the study and t is the time elapsed from the start
to the time when the tumour volume is V. T2 is the volume doubling time (or
the time during which the size of the tumour is doubled).
In Fig. 4 the growth of the metastases of a tumour of the kidney is shown.
One of the metastases was treated with X-rays. 5 months later the patient
received chemotherapy. This stopped the growth of the previously untreated
metastases, while the X-ray-treated one progressed with a probably somewhat
reduced growth rate. Observations of this kind, when systematically performed,
would certainly be valuable in judging the use of various methods of treatment.
The decrease in volume as a result of some kind of treatment is a matter of
special interest. The curves shown in Fig. la illustrate this situation. In the
case of a hypernephroma the kidney was surgically removed at the time A.
After a slight increase or a period of constant volume the pulmonary metastases
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disappeared. A small nodule of one of the metastases remained some 6 months
after the surgical measure, while the other had disappeared by that time. In a
later picture no metastases were left. We must assume that this effect was due
to some kind of host factor. The phenomenon is unusual.
Any sign of a real decrease in tumour size or even decrease in growth rate
must be considered important. A graphical study of the volume ofthe neoplasm
as a function ofthe time will be the first step toward a sensitive method ofstudying
changes in tumour size and their reasons.
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FIG. 4.- The growth of metastases of a hypernephroma. The doubling time obtained from the
three first points (lower curve) is 2 - 0 ± O*2 months.
EVIDENCE OF EXPONENTIAL GROWTH
As a result of the investigations of several authors (Schwartz, 1961 ; Breur,
1965, 1966) at least a rough linearity ofthe growth curve is seen when the volume
or the diameter of human tumours is plotted on semilogarithmic paper. The
reasons for any deviation from this linearity cannot be explained as real changes
in growth rate until the size of the error is estimated. As mentioned above, the
error may be caused by several factors, and it is very difficult to calculate. By
remeasuring the same shadow and comparing similar radiographs taken of the
same neoplasm within a short period of time, we have found that there may be
an error as large as 20-30% in the volume or 7-10% in diameter of primary lung
tumours. These have fairly diffuse boundaries and the shape is usually irregular.
Even these errors do not refer to the real volume, but rather to the " relative
volume ". The ratio of the latter to the real volume depends not only on the
shape but also on the subjectivity of the person who examines and measures the
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shadows. Thus one person should measure all points belonging to the same curve.
In the case of metastases of hypernephroma which have sharp boundaries, the
error is smaller. A 7-10% error was estimated for their volume.
The results of measurements on the growth rate of cancer of the lung is shown
in Fig. 5. It is readily seen that a straight line fits all these tumours which
represent the complete material of untreated cancer of the lung studied by us.
In Fig. 2 is seen the growth curve of the metastases of a hypernephroma. The
record covers a long period of time during which the linearity is preserved. The
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FIG. 5.-Growth curves of primary tumours (solid curve) and metastases broken curves of lung
cancer (see Table I).
entire material of untreated metastases showed only linear curves on semilog
paper. It can be concluded that the material studied by us gives evidence for the
validity ofan exponential growth pattern ofhuman tumours and their metastases.
Some of our measurements (Table I) would cover about 30% of the entire growth
period as estimated, ifthe exponential relationship is assumed to last even through
the silent period of growth after the genesis of the carcinoma. The relatively small
number of cases studied by us does not, however, allow of too definite conclusions
on the validity of the exponential growth in general. The exponential relation-
ship has been discussed by us in a previous paper (Holsti, Brenner, Holsti and
Perttala, 1966). We are aware of the fact that the error of our measurements in
most cases makes the detection of small changes in the growth rate impossible.
No convexity upwards has been observed by us. Such a convexity observed in
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aniimal tumours (Mendelsohn. 1963 ; Laird. 1964) has been assurimed bv Steel and
Lamerton (1966) in human tumours as well. They stress the fact that a wide
variety of non-exponential algebraic functions can be found to fit data which
comprise only a 20-fold to 100-fold increase in tumour volume. The increase in
tumour volume ofour data is listed in the fifth column ofTable I. More thaln half
our cases have an increase smaller than 10 and only 7 cases give an increase
bigger than 20. It is thus in nearly all cases impossible to draw any conclusioni
about the growth pattern during the silent period of growth before the roentgeilo-
graphic observation. Mendelsohn (1965) has proposed the use of another function
whichl can be written:
dV k Vb (2)
when the volume V is considered and k and b are constants. If b has the value I
this function gives the exponential law expressed by equation (1). A smaller
value of b would give the convexity upwards. The biggest increase in tumour
volume is 500 and 93 for two primary tumours ofthe lung (EH and EET ofFig. 5).
If we try to get a minimum of b which still gives a function that fits the data we
get for EH b > 0 8 and for EET b > 0 9. The data for EET are thus expected
to give a fairly constant doubling time back in the silent period of growth while
EH can be fitted with a growth curve which has a higher growth rate in this
period than observed by us. Still, we wish to get more reliable data to be able
to make conclusions.
THE GROWTH RATE AFTER TREATMENT
In a few cases we have observed that when the growth starts again after the
decrease in tumour volume following radiotherapy or chemotherapy. the rate is
roughly the same as before treatment. Similar observations have been made by
Breur (19.65. 1966). In some cases there are small differences between growth
rates before and after treatmeint. Our material is, for the moment, too small to
give a definite answer to the question whether the growth rate can be changed
by treatment. If the growth rate is the same after treatment as before. one finds
that in slow growing tumours a certain decrease in volume caused by treatment
results in a longer " remission " or delay than in rapidly growing tumours experi-
encing the same decrease. The delay td can be calculated from the expression
t- T2 . 0-301l V0 (3)
where log (V0/ V) is common logarithm of the ratio of the volume before and after
the treatment. Here we have assumed that the duration of the treatment is
short compared to td. The delay can be read from the growth curves directly?
as shown in Fig. 4. Measurements of the decrease of volume are easier after
chemotherapy than after radiotherapy, which causes pneumonitis and fibrosis in
the lung tissue.
DETERMINATION OF THE DOUBLING TIMIE
As is demonstrated in Fig. 1-6 the doubling time of clinical tumours can be
studied by measurement of pulmonary metastases or peripheral primarv cancers
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in serial roentgenograms. It can be read directly from the logarithmic curves.
This doubling time, however, refers only to the clinically detectable period. If
it were constant during the entire history of the tumour it could be used to esti-
mate the time of induction of malignancy. Although this assumption may be
wrong, a calculation of the hypothetical age of the tumour or the metastases may
be of some interest. At least this figure should be an upper estimate of the real
age. In Table I are listed the doubling times obtained from our measurements.
As the calculation ofthe appendix shows, the error in doubling time is proportional
to the ratio of the doubling time and the time of observation. The error is
indicated for every doubling time.
time one month per scale div.
FIG. 6. Estimation of the growth rate of fast-growing metastasis of an osteogenic sarcoma.
T2 6d.
As for the lung tumours, the results are in good accord with those of Garland,.
Coulson and Wollin (1963). The mean doubling time of our lung tumours is
3*1 months. Garland, Coulson andWollinfoundno significant difference in growth
rate between histological subgroups. Our material of metastases of hyper-
nephroma shows a slow-moving group of three cases with a doubling time of
approximately 8 months, and another group of six cases, with a doubling time
near 13 months. Similarly, the four cases of mammary cancer metastases have
two different doubling times. Two of the cases have about 10 months and two
about 1 month. The five cases of mammary cancer reported by Breur (1965):
seem to be divided into two distinct groups accordingly. One ofthe groups has a
mean doubling time of 5-6 months and the other of 14 months. We cannot make
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any decision as to the real existence of distinct groups of hypernephroma and
mammary cancer because of the small number of the cases. The mean doubling
time of the metastases of Ca colli uteri is 1-3 months (one case with T2 > 8 is
observed). The shortest doubling time estimated is less than 6 days and is due
to metastases of a sarcoma of bone (Fig. 6).
From the point of view of the use of different fractionation schemes in radio-
therapy (Fowler, 1966 ; Holsti, 1966; Holsti and Taskinen, 1966) it is important
to note that the doubling time of most human tumours is much longer than the
renewal time of proliferating normal tissues.
DISCUSSION
Since the introduction ofthe concept ofexponential growth pattern for tumours
by Collins et al. (1956) there have been justified arguments against its validity
(e.g. Rigler, 1965; Steel and Lamerton, 1966). On the other hand, there is a lot
of evidence for exponential growth of tumours and metastases of the lung during
the clinically detectable period of growth (Collins et al., 1956 ; Schwartz, 1961;
Spratt and Spratt, 1964; Breur, 1965; Holsti, Brenner, Holsti and Perttala,
1966). Exponential growth should be looked for in a homogenous environment
such as lung tissue so that necrosis does not affect the growth pattern, and host
factors, such as feedback and immunity, remain constant. The study of tumours
and metastases which meet these conditions partially or fully will have relevance
to the following problems and concepts: (1) The determination of the cell popula-
tion or volume doubling time by means of a semi-logarithmic plot. The doubling
time, however, is well defined only for exponentially growing tumours. The
doubling time, together with some kind of mitotic index or data regarding cell
cycle time, will give information on the growth of cell populations and especially
on the ratio of proliferative and non-proliferative cells. (2) By some kind of
extrapolation backwards it would be theoretically possible to estimate the time
of induction of the malignancy. This would presuppose that the tumour grows
at exactly the same rate throughout its course. Our observations-on the exponen-
tial growth of tumours, however, are restricted to the clinically detectable period
of growth.
W17e do not know anything about the growth pattern during the silent period
of growth of human tumours. From a clinical point of view the most important
thing, however, is not to be able to estimate exactly when a tumour has started
to grow, but to learn to understand that tumour growth may be a much longer
and slower process than was generally believed. In that sense, this manner of
thinking in accordance with this hypothesis is of value as a base for discussion
in clinical practice. One more factor must be taken into consideration. Calcula-
tions with extrapolation backwards until the induction of malignancy are based
on the assumption that a tumour begins from one cell. This has, however, not
been proved. In fact there is some evidence to indicate that they arise from
fields of cells or tissue (Willis, 1960).
In so far as exponential growth can be considered the normal pattern of
growth during the clinically detectable period of growth of human tumour, it is
justifiable to define a doubling time for this period of tumour growth. The
determination of the growth rate and of the doubling time is very important in
clinical work, not only for acceptance of the fact that many tumours grow slowly,
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but also from the viewpoint of therapy, in which these factors can be of use, in
many ways.
SUMMARY
On the basis of 34 series ofradiographs of the chest representing primary lung
cancer and pulmonary metastases of different origin, growth curves have been
drawn on semilogarithmic paper. The object was to discover what can be deter-
mined from the tumour-growth curves obtained. The following aspects have
been discussed: evidence of exponential growth, changes of growth rate during
treatment, growth rate after treatment, decrease of tumour volume and the
determination of doubling times. The discussion serves as a basis for future
studies.
This investigation was supported by a grant from the Sigrid Juselius Founda-
tion, Helsinki.
Two of us (M.W.B. and L.R.H.) are indebted to Professor Lamerton and Dr.
Steel at the Institute of Cancer Research, Sutton, for valuable discussions.
APPENDIX
The error of the doubling time
Let us assume that the radiographs were taken at even intervals during the
time of observation, Tobs. This distribution is referred to as the type 1 in Fig. 7.
The length of each interval is thus Tobs/(k - 1), where k is the number of radio-
graphs. The volume ofthe tumour is given by equation (1). We take the natural
logarithm of (1) and get
lnV =lnVo + n2 t (4)
2
a linear relationship of the logarithm with respect to the time, as is illustrated in
the graphs (e.g. Fig. 2 and 5). Now the standard error S' of the coefficient
1n2/T2 is
V (k-1) [k , t- ( tn)2]
it n
where S,, is the standard error of the measured volume (Beers, 1953). As the
relative (standard) error we take S' divided by ln2/T2. It is equal to the error
of T2 (which we write ST) divided by T2. Moreover, the relative standard error
of the volume is Sv/V. We can now evaluate the expression under the square
root ifwe introduce the instant oftime oftheradiographstn = (n - 1) Tobs/(k- 1).
This gives
ST VA2SI, T2 1
T2 In2 V Tobs '/k1 (6)
From the last equation we see that the error of the doubling time is small if the
time of observation is long compared with the doubling time. Moreover, a
great number of radiographs as well as a small relative error in tumour volume
reduces the relative error of the doubling time.
In a similar way we can derive an expression for the error in the extreme case
when half of the radiographs are taken at the beginning and the other half at the
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end of the observation time (type 2 of Fig. 7). This gives a good estimate of
the doubling time but no check of the exponentiality of the growth. Two more
extreme cases give other expressions as illustrated in the Fig. 7. They are:
one radiograph taken at the beginning and all the others at the end ofthe observa-
tion time (type 3) and, finally, one taken at the beginning, one at the end, and
all the others at the middle of the observation time (type 4). To illustrate the
effect of the different distributions, the third column of the figure gives the error
in a typical case of6 radiographs taken during an observation time oftwo doubling
Distribution Expression for the Typical relative error of ero type the doubl ng time error
1 T2j-jpSv _n2 v Tobs k+1 940/
2 %% ~~~2.S. 2- W6,40/
In2 v Tobs 'k6i
3 1 ~~Sv T2 k
1n2 v Tobs k-1 8,6%/0
4 liS V1 t ln2s
11,0%/ n2VTabs k-i
Fia. 7.-The relative standard error of the doubling time in four different cases of distribution
in time of radiographs.
times ifthe error ofthe volume determination is 10%. As seen from these values
the distributions give roughly the same errors except for the non-realistic type 2,
which gives a considerably smaller-error than the other. The distribution of
type 1 can therefore be applied in practically all cases to get an estimation of the
error. This procedure is of course much less tedious than the use ofthe equation
(5).
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